- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 894-908 of
1,261 results
2097 Exhibit: EX2097 García Casares, N, et al, Effects of GLP 1 receptor agonists ...
Document
IPR2023-00724, No. 2097 Exhibit - EX2097 García Casares, N, et al, Effects of GLP 1 receptor agonists on neurological complications of diabetes, Rev Endocr Metab Disord, 24655 672 2023 (P...
|
|
Cite Document
2080 Exhibit: EX2080 Dhruv Khullar, “The Year of Ozempic,” New Yorker, Decembe...
Document
IPR2023-00724, No. 2080 Exhibit - EX2080 Dhruv Khullar, “The Year of Ozempic,” New Yorker, December 14, 2023, available at httpswwwnewyorkercomculture2023 in reviewthe year of ozemp...
|
|
Cite Document
2465 Exhibit: EX2465 US Food Drug Administration, DrugsFDA, Steglatro
Document
IPR2023-00724, No. 2465 Exhibit - EX2465 US Food Drug Administration, DrugsFDA, Steglatro (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2408 Exhibit: EX2408 US Food Drug Administration, DrugsFDA, Victoza®
Document
IPR2023-00724, No. 2408 Exhibit - EX2408 US Food Drug Administration, DrugsFDA, Victoza® (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2441 Exhibit: EX2441 Jardiance® Prescribing Information rev Dec 2016
Document
IPR2023-00724, No. 2441 Exhibit - EX2441 Jardiance® Prescribing Information rev Dec 2016 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
1040 Exhibit: Vilsboll 2009
Document
IPR2023-00724, No. 1040 Exhibit - Vilsboll 2009 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
3003 Exhibit: Email from Megan Raymond To Trials Cc white ptabBeel, Bryan D gre...
Document
IPR2023-00724, No. 3003 Exhibit - Email from Megan Raymond To Trials Cc white ptabBeel, Bryan D greb ptab prochnowptab jones ptab tietz pta lembo ptab Novo Semaglutide Subject IPR2023...
|
|
Cite Document
1015 Exhibit: WO537
Document
IPR2023-00724, No. 1015 Exhibit - WO537 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
1019 Exhibit: Bell 1983
Document
IPR2023-00724, No. 1019 Exhibit - Bell 1983 (P.T.A.B. Mar. 16, 2023)
|
|
Cite Document
2524 Exhibit: EX2524 Eli Lilly Co, 2019 Financial Report
Document
IPR2023-00724, No. 2524 Exhibit - EX2524 Eli Lilly Co, 2019 Financial Report (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2382 Exhibit: EX2382 Boyes, KS, et al, Physician Perceptions of Dose Escalation f...
Document
IPR2023-00724, No. 2382 Exhibit - EX2382 Boyes, KS, et al, Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States, Diabetes Ther, 2023 Nov, httpsdoio...
|
|
Cite Document
2351 Exhibit: EX2351 National Institute of Diabetes and Digestive Kidney Diseases...
Document
IPR2023-00724, No. 2351 Exhibit - EX2351 National Institute of Diabetes and Digestive Kidney Diseases, “What is Diabetes,” httpswwwniddknihgovhealth informationdiabetesoverviewwhat is di...
|
|
Cite Document
1093 Exhibit: Beel Declaration
Document
IPR2023-00724, No. 1093 Exhibit - Beel Declaration (P.T.A.B. Dec. 18, 2023)
|
|
Cite Document
2001 Exhibit: EX2001 US Patent No 9,764,003 File History
Document
IPR2023-00724, No. 2001 Exhibit - EX2001 US Patent No 9,764,003 File History (P.T.A.B. Jul. 6, 2023)
|
|
Cite Document
2100 Exhibit: EX2100 Leiter, LA, et al, Cardiovascular risk reduction with once wee...
Document
IPR2023-00724, No. 2100 Exhibit - EX2100 Leiter, LA, et al, Cardiovascular risk reduction with once weekly semaglutide in subjects with type 2 diabetes a post hoc analysis of gender, age, and ...
|
|
Cite Document
